Mar 2018: HbA1c 10.3%/89, FBG 15.6. BMI 25. Non-HDL-C 4.8 mmol/l. BP 165/95
Sep 2018: HbA1c 5.8%/40, FBG 5.0. BMI 23. Non-HDL-C 2.2 mmol/l. BP 115/75
Oct 2024: HbA1c 5.5%/37, FBG 4.7. BMI 20. Non-HDL-C 1.3 mmol/l. BP 107/65
T2D reversed via weight loss.
T2D legacy problems: Peripheral artery disease/obliterans; mild-moderate background NP retinopathy.
Meds: Rosuvastatin 20mg. Fenofibrate 145mg (for retinopathy).
Eating: Mainly plants with lots of nuts & seeds.
Exercise: Physical Activity Level at 1.8 average, mainly via walking
